eCTD baseline submissions are a feature of many drug product application processes. Phil Kerr, Regulatory Affairs Manager at G&L, takes a deeper look at their importance and why they should be an ...
Before visiting our new website www.gandlhealth.com it is advised to clear your Internet Browser cache to remove any cookies or trackers from the previous website.
As 2022 draws to an end, political, economic and social instability continue to dominate the headlines. With the impacts being felt far and wide and predicted to last into 2024, Paul Kuiken, ...
Mental health is one of the biggest and most pressing concerns in modern society. As scientific research into the many causes and treatments remains as vital as ever, Megan Wilmot from G&L’s ...
Sandra Maguire, Senior Manager, Regulatory Affairs at G&L, looks at new guidelines issued by the ICH and outlines the objectives and potential benefits of the proposals on Analytical Procedure ...
